Bhawan J, Gonzalez-Serva A, Nehal K, Labadie R, Lufrano L, Thorne E G, Gilchrest B A
Department of Dermatology, Boston (Mass) University School of Medicine 02118.
Arch Dermatol. 1991 May;127(5):666-72.
The histologic effects of topical tretinoin therapy on photodamaged facial skin were investigated in two 24-week, double-blind, randomized, vehicle-controlled studies involving 533 subjects at eight US centers. Three concentrations of tretinoin (0.05%, 0.01%, and 0.001%) in a new emollient cream were studied. Pretherapy and posttherapy biopsy specimens from the periorbital (crow's foot) area were examined by conventional light microscopy and computerized image analysis. Four significant dose-dependent differences from vehicle were found in the tretinoin groups: increased epidermal thickness, increased granular layer thickness, decreased melanin content, and stratum corneum compaction. There was no significant difference between 0.001% tretinoin and the vehicle, and no obvious dermal changes were detected in any group. The four epidermal changes in tretinoin-treated skin establish the biologic activity of the new emollient cream formulation and may partially account for the clinical improvements in photodamage observed in the same group of subjects.
在美国八个中心进行了两项为期24周的双盲、随机、赋形剂对照研究,涉及533名受试者,调查了外用维甲酸治疗对面部光损伤皮肤的组织学影响。研究了新润肤霜中三种浓度的维甲酸(0.05%、0.01%和0.001%)。通过传统光学显微镜和计算机图像分析检查眶周(鱼尾纹)区域治疗前和治疗后的活检标本。在维甲酸组中发现与赋形剂有四个显著的剂量依赖性差异:表皮厚度增加、颗粒层厚度增加、黑色素含量降低和角质层致密化。0.001%维甲酸与赋形剂之间无显著差异,且任何组均未检测到明显的真皮变化。维甲酸治疗皮肤的四种表皮变化证实了新润肤霜配方的生物活性,并且可能部分解释了在同一组受试者中观察到的光损伤临床改善情况。